Overview

Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This is a dose-finding study to determine if the sublingual administration of the Sufentanil NanoTab is safe and effective in the treatment of post-operative pain.
Phase:
Phase 2
Details
Lead Sponsor:
AcelRx Pharmaceuticals, Inc.
Treatments:
Dsuvia
Sufentanil